ForecastCONTRACT
Histopathology and antibody screening of Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic preclinical trial samples.
NATIONAL INSTITUTES OF HEALTHHEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH OLAO
AI Overview
NIH seeks histopathology analysis and antibody screening services for Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic trial samples. Limited details available.
This summary is AI-generated from the official solicitation.
Key Details
Agency
NATIONAL INSTITUTES OF HEALTH
Funding Amount
—
Release Date
July 9, 2026
Due Date
July 20, 2026
Official Description
See attached
⚠️ Note: The SAM.gov API does not provide detailed information for this opportunity. Full details may be available in attached documents or by contacting the point of contact directly.
Change History
Opportunity AddedJul 9, 2026 at 9:03 PM
Histopathology and antibody screening of Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic preclinical trial samples.
New SAM.gov opportunity: Histopathology and antibody screening of Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic preclinical trial samples.
Similar Opportunities
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial